Nova Scotia has released the December Pharmacists’ Bulletin Volume 09-11. Highlights include new products added to the Nova Scotia Formulary.
ONTARIO
Ontario has released Update O to the ODB Formulary, effective January 5, 2010.
MANITOBA
Manitoba has released Bulletin # 62 to the Manitoba Drug Benefits and Interchangeability Formulary Amendments which takes effect on February 18, 2010.
BRITISH COLUMBIA
BC PharmaCare Newsletter Edition 09-019 has been released. Highlights include an Interim Agreement Update between BC Pharmacy Association and the government of BC.
BC PharmaCare Newsletter Edition 10-001 has been released. Highlights include Proton Pump Inhibitors – Expanded Coverage.
CADTH
CADTH has made an amendment to their HTA Rapid Review: Portable Monitoring Devices for Diagnosis of Obstructive Sleep Apnea at Home: Review of Accuracy, Cost-Effectiveness, Guidelines, and Coverage in Canada.
CADTH has released CDR Update Issue 67. Highlights include CEDAC Announcements and CEDAC Recommendations.
CADTH has released COMPUS Communiqué Volume 5, Number 7. Highlights include Self-Monitoring of Blood Glucose: New Tools to Support Recommendations.
PMPRB
Voluntary Compliance Undertaking (‘’VCU’’)
On January 26, 2010, the Chairman of the Board approved a VCU from Bayer Inc. in relation to the medicine Xarelto (rivaroxaban), which is indicated for the prevention of venous thromboembolic events in patients who have undergone elective hip or total knee replacement surgery. According to the VCU, Xarelto’s price exceeded the PMPRB’s international price guideline at introduction and in 2009. Bayer has undertaken to offset cumulative excess revenues accrued from September 18, 2008 to June 30, 2009 by making a payment to the Crown in the amount of $49,978.33. Bayer also undertakes to make further payment to Her Majesty for any additional excess revenues received after June 30, 2009.
